The future of best investing in vaccines: the Health Technology Assessment approach

Giuseppe La Torre; Chiara De Waure; Giacomina Chiaradia; Alice Mannocci; Maria Lucia Specchia; Nicola Nicolotti; Walter Ricciardi

doi:10.1016/j.vaccine.2008.01.009

The future of best investing in vaccines: the Health Technology Assessment approach

Giuseppe La Torre, Chiara De Waure, Giacomina Chiaradia, Alice Mannocci, Maria Lucia Specchia, Nicola Nicolotti, Walter Ricciardi

Risultato della ricerca: Contributo in rivista › Articolo in rivista

13 Citazioni (Scopus)

Abstract

Over the past two decades, scientific research has led to the development of a huge number of new health technologies, among which new vaccines. The decision process underlying the introduction of a new vaccine will be of particular concern in the future and a useful tool is needed to orientate decision makers towards better allocation of economic resources. Health Technology Assessment (HTA) is a multidisciplinary tool that aims to examine the clinical, economic, organizational, ethical, juridical, social and cultural implications of the introduction or the implementation of a specific technology; it could so represent an innovative and effective approach in order to support decision-making processes.

Lingua originale	English
pagine (da-a)	1609-1610
Numero di pagine	2
Rivista	Vaccine
Volume	26
DOI	https://doi.org/10.1016/j.vaccine.2008.01.009
Stato di pubblicazione	Pubblicato - 2008

Keywords

Biomedical Technology
Drug Industry
Health Care Costs
Health Expenditures
Humans
Infection Control
Vaccines

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.1016/j.vaccine.2008.01.009

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{cc0e92bf255e4b268e7ed3b3ce327c75,

title = "The future of best investing in vaccines: the Health Technology Assessment approach",

abstract = "Over the past two decades, scientific research has led to the development of a huge number of new health technologies, among which new vaccines. The decision process underlying the introduction of a new vaccine will be of particular concern in the future and a useful tool is needed to orientate decision makers towards better allocation of economic resources. Health Technology Assessment (HTA) is a multidisciplinary tool that aims to examine the clinical, economic, organizational, ethical, juridical, social and cultural implications of the introduction or the implementation of a specific technology; it could so represent an innovative and effective approach in order to support decision-making processes.",

keywords = "Biomedical Technology, Drug Industry, Health Care Costs, Health Expenditures, Humans, Infection Control, Vaccines, Biomedical Technology, Drug Industry, Health Care Costs, Health Expenditures, Humans, Infection Control, Vaccines",

author = "{La Torre}, Giuseppe and {De Waure}, Chiara and Giacomina Chiaradia and Alice Mannocci and Specchia, {Maria Lucia} and Nicola Nicolotti and Walter Ricciardi",

year = "2008",

doi = "10.1016/j.vaccine.2008.01.009",

language = "English",

volume = "26",

pages = "1609--1610",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier Science Limited:Oxford Fulfillment Center, PO Box 800, Kidlington Oxford OX5 1DX United Kingdom:011 44 1865 843000, 011 44 1865 843699, EMAIL: [email protected], [email protected], INTERNET: http://www.elsevier.com, http://www.elsevier.com/locate/shpsa/, Fax: 011 44 1865 843010",

}

TY - JOUR

T1 - The future of best investing in vaccines: the Health Technology Assessment approach

AU - La Torre, Giuseppe

AU - De Waure, Chiara

AU - Chiaradia, Giacomina

AU - Mannocci, Alice

AU - Specchia, Maria Lucia

AU - Nicolotti, Nicola

AU - Ricciardi, Walter

PY - 2008

Y1 - 2008

N2 - Over the past two decades, scientific research has led to the development of a huge number of new health technologies, among which new vaccines. The decision process underlying the introduction of a new vaccine will be of particular concern in the future and a useful tool is needed to orientate decision makers towards better allocation of economic resources. Health Technology Assessment (HTA) is a multidisciplinary tool that aims to examine the clinical, economic, organizational, ethical, juridical, social and cultural implications of the introduction or the implementation of a specific technology; it could so represent an innovative and effective approach in order to support decision-making processes.

AB - Over the past two decades, scientific research has led to the development of a huge number of new health technologies, among which new vaccines. The decision process underlying the introduction of a new vaccine will be of particular concern in the future and a useful tool is needed to orientate decision makers towards better allocation of economic resources. Health Technology Assessment (HTA) is a multidisciplinary tool that aims to examine the clinical, economic, organizational, ethical, juridical, social and cultural implications of the introduction or the implementation of a specific technology; it could so represent an innovative and effective approach in order to support decision-making processes.

KW - Biomedical Technology

KW - Drug Industry

KW - Health Care Costs

KW - Health Expenditures

KW - Humans

KW - Infection Control

KW - Vaccines

KW - Biomedical Technology

KW - Drug Industry

KW - Health Care Costs

KW - Health Expenditures

KW - Humans

KW - Infection Control

KW - Vaccines

UR - http://hdl.handle.net/10807/30656

U2 - 10.1016/j.vaccine.2008.01.009

DO - 10.1016/j.vaccine.2008.01.009

M3 - Article

SN - 0264-410X

VL - 26

SP - 1609

EP - 1610

JO - Vaccine

JF - Vaccine

ER -

The future of best investing in vaccines: the Health Technology Assessment approach

Abstract

Keywords

OSS delle Nazioni Unite

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo